Masaki Takao

发表

Clinical Study of Intravenous, Low-Dose Recombinant Tissue Plasminogen Activator for Acute Cerebral Infarction: Comparison of Treatment within 3 Hours versus 3-4.5 Hours.

Ichiro Deguchi, Norio Tanahashi, Masaki Takao, 2018, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Pathologic findings of silent hyperintense white matter lesions on MRI

Makoto Takagi, Y. Fukuuchi, S. Morinaga, 1999, Journal of the Neurological Sciences.